dual mu opioid/5-HT4 agonists (Sunovion)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual mu opioid/5-HT4 agonists (Sunovion)
Drug Alias Namedual mu opioid/5-HT4 agonists (Sepracor)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonistsMu opioid receptor agonists
TargetsSerotonin 4 (5-HT4) receptorMu opioid receptor
Therapy Area/IndicationsConstipationPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSunovion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsConstipationPain

Other Information

ATC CodeN/A
Related LinksN/A